BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
+11.77%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$894M
AUM Growth
+$894M
(-7.9%)
Cap. Flow
-$62M
Cap. Flow
% of AUM
-6.93%
Top 10 Holdings %
Top 10 Hldgs %
76.13%
Holding
32
New
–
Increased
2
Reduced
6
Closed
1
Top Buys
| 1 |
Tango Therapeutics
TNGX
|
$10.9M |
| 2 |
Savara
SVRA
|
$9.87M |
Top Sells
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$30.6M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
$23.6M |
| 3 |
Dynavax Technologies
DVAX
|
$22.2M |
| 4 |
THRD
Third Harmonic Bio
THRD
|
$3.08M |
| 5 |
Pharvaris
PHVS
|
$1.76M |
Sector Composition
| 1 | Healthcare | 98.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nuvalent
NUVL
$5.52B
| $164M | 18.39% | 3,577,267 | – | – |
|
|
2
Pharvaris
PHVS
$1.39B
| $99.9M | 11.17% | 4,784,674 -84,110 | -2% | -$1.76M |
|
3
NewAmsterdam Pharma
NAMS
$2.71B
| $96.9M | 10.83% | 10,473,913 | – | – |
|
|
SWTX
4
DELISTED
SpringWorks Therapeutics
SWTX
| $71.2M | 7.97% | 3,081,307 | – | – |
|
5
Disc Medicine
IRON
$2.07B
| $62.6M | 7% | 1,332,545 -3 | -0% | -$141 |
|
|
6
Savara
SVRA
$567M
| $53.8M | 6.02% | 14,232,751 +2,610,153 | +22% | +$9.87M |
|
|
7
Crinetics Pharmaceuticals
CRNX
$2.92B
| $37.9M | 4.24% | 1,275,552 -1,030,006 | -45% | -$30.6M |
|
|
8
Tango Therapeutics
TNGX
$747M
| $32.6M | 3.64% | 2,892,663 +970,873 | +51% | +$10.9M |
|
9
Natera
NTRA
$23.1B
| $31M | 3.46% | 700,197 | – | – |
|
10
Cabaletta Bio
CABA
$133M
| $30.4M | 3.4% | 2,000,000 | – | – |
|
11
Aclaris Therapeutics
ACRS
$209M
| $23.3M | 2.6% | 3,400,000 | – | – |
|
|
EQRX
12
DELISTED
EQRx, Inc. Common Stock
EQRX
| $22.2M | 2.48% | 10,003,573 | – | – |
|
13
X4 Pharmaceuticals
XFOR
$84.2M
| $17.4M | 1.95% | 15,960,588 | – | – |
|
14
Arcutis Biotherapeutics
ARQT
$1.86B
| $15.9M | 1.78% | 3,000,000 | – | – |
|
15
Nurix Therapeutics
NRIX
$714M
| $14.3M | 1.6% | 1,822,883 | – | – |
|
|
CBAY
16
DELISTED
Cymabay Therapeutics
CBAY
| $13.6M | 1.52% | 913,969 -1,586,031 | -63% | -$23.6M |
|
|
17
Dynavax Technologies
DVAX
$1.19B
| $13.5M | 1.51% | 915,000 -1,500,000 | -62% | -$22.2M |
|
18
Annexon
ANNX
$226M
| $13.5M | 1.5% | 5,701,926 | – | – |
|
|
MRNS
19
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $11.5M | 1.29% | 1,431,058 | – | – |
|
20
Mersana Therapeutics
MRSN
$36.5M
| $11M | 1.23% | 8,663,673 | – | – |
|
21
Rapid Micro Biosystems
RPID
$107M
| $9.11M | 1.02% | 8,434,560 | – | – |
|
|
SYRS
22
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $8.39M | 0.94% | 2,124,694 | – | – |
|
23
Solid Biosciences
SLDB
$427M
| $7.89M | 0.88% | 3,130,422 | – | – |
|
24
Atea Pharmaceuticals
AVIR
$267M
| $7.46M | 0.83% | 2,485,638 | – | – |
|
25
Nautilus Biotechnolgy
NAUT
$85.9M
| $6.32M | 0.71% | 2,000,000 | – | – |
|